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Abstract
Urogenital schistosomiasis is a chronic infection caused by the human blood fluke Schistosoma 
haematobium. Schistosomiasis haematobium is a known risk factor for cancer leading to 
squamous cell carcinoma of the urinary bladder (SCC). This is a neglected tropical disease 
endemic in many countries of Africa and the Middle East.
Schistosome eggs produce catechol-estrogens. These molecules are metabolized to active quinones 
that cause alterations in DNA (leading in other contexts to breast or thyroid cancer). Our group 
have shown that schistosome egg associated catechol estrogens induce tumor-like phenotypes in 
urothelial cells, originated from parasite estrogen-host cell chromosomal DNA adducts and 
mutations.
Here we review recent findings on the role of estrogen–DNA adducts and how their shedding in 
urine may be prognostic of schistosome infection and/or represent potential biomarkers for 
urogenital schistosomiasis associated bladder cancer and infertility.
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Urogenital schistosomiasis
Schistosomiasis is a parasitic disease that infects an estimated 243 million people 
worldwide, and every year kills about 200 thousand [1,2]. It is contracted through 
contaminated waters, a disease of the developing world where is 2nd only to malaria in rates 
of infection and public health impact [3].
This infectious disease is acquired when the parasite larvae enter the skin in contact with 
contaminated waters. The larvae live in blood vessels for up to 5 years releasing eggs, which 
are excreted to the outside to infect snails and start a new parasite’s life cycle. However, 
many eggs are not excreted but get stuck in the patient’s tissues and organs triggering an 
immune response that causes chronic inflammation and destruction of these tissues [4].
The most prevalent human Schistosoma species is Schistosoma (S.) haematobium, which 
affects the urogenital system and may cause bladder cancer [5,6]. In women, the cervix and 
the uterus are often affected causing female genital schistosomiasis (FGS), which produces 
infertility, as well as bleeding and pain during sexual intercourse [7]. In countries with little 
access to information and medical care, this type of problems may result in stigmatization 
and other negative social consequences to women, as fertility remains central for their 
identity and discussion of sexual problems is a taboo in many ethnic groups of endemic 
areas. Around 40 million women of childbearing age are estimated to be infected [3,8].
Estrogen metabolites as biomarkers of urogenital schistosomiasis
An appalling elevation in levels of estradiol but not luteinizing hormone (LH) or testosterone 
in sera was observed in human cases of urogenital schistosomiasis for the study of hormones 
in this infection [9].
Estradiol is an hormone belonging to the steroid superfamily mainly produced by the 
follicles of ovaries from vertebrates. We questioned if the elevated levels in these cases could 
be attributed to hypothalamic-pituitary gonadal axis regulations. Instead, we hypothesized 
that schistosomes produced estradiol-related molecules and these molecules contributed to 
the increased estradiol levels.
Next, using LC-MS-MS (Liquid Chromatography coupled with Mass Detector) techniques 
we characterized estradiol related molecules, from sera of S. haematobium-infected persons 
and, noteworthy, in the parasites including the eggs [10].
As shown previously by our group, we identified and characterized by LC-MS-MS novel 
catechol estrogens in schistosome worms and infected person’s sera and urine.
The molecules named catechol-estrogens are synthesised by a reaction of hydroxylation on 
the steroid aromatic ring A component of the steroid molecule. This hydroxylation of the 
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atoms of carbon #2 and #3 of the steroid molecule led to a further reaction of oxidation 
creating another molecule called estradiol-2,3-quinone. We have speculated that reactive 
catechol-estrogens from schistosome eggs play a decisive act in urogenital schistosomiasis 
associated bladder cancer (Figure 1) [4,10] and infertility [3,11].
Molecular mechanism underlying schistosome estrogen catechols in 
cancer and infertility
Given the context of the unarguable link between S. haematobium infection and bladder 
cancer, the presence of putative carcinogenic molecules in S. haematobium eggs hopefully 
may have practical consequences for new approaches to disease control [5,10]. Metabolism 
of estrogens and the production of depurinating estrogen–DNA adducts can be implicated in 
a pathway underlying S. haematobium-promoted host cell DNA damage, leading eventually 
to cell transformation. The carcinogenic effect of this estrogen–DNA adduct mediated 
pathway could explain the link between chronic schistosomiasis haematobia and SCC of the 
bladder [10]. We anticipate that these findings will contribute to understanding how 
schistosomiasis haematobia leads to SCC of the bladder.
Hormonal disturbances in women with FGS may be linked to infertility and suboptimal 
fecundity [3,11]. Recently, estrogen-like metabolites were detected by LC–MS in urine of S. 
haematobium-infected women. These metabolites are similar to those identified previously 
in the adult worm and egg stages of S. haematobium [10]. The presence of estrogen-like 
metabolites during FGS was statistically associated with self-reported infertility [3]. These 
electrophilic compounds can react with DNA to form depurinating adducts. It is not 
inconceivable that apurinic sites in chromosomal DNA that result from this reaction generate 
mutations that might underlie infertility [3,11].
The impact of Mass Spectrometry as a diagnostic and prognostic tool in 
schistosomiasis associated cancer and infertility
Only a few years ago, the bladder cancer and female infertility observed in schistosomiais 
infected individuals were assumed to result exclusively from the tissue apoptosis caused by 
the immune response against the entrapped eggs.
We have been working for more than 10 years with S. haematobium and felt that a shift in 
this paradigm was needed. This shift happened after discovering and identifying estrogen-
like molecules circulating in patients infected with schistosomiasis that potentially cause 
cancer [5,10]. Recently, we observed these molecules not only circulating in the blood of 
infected patients but also in the urine of these patients. We observed in the urine of infected 
women (but not on healthy individuals) catechol-estrogens. These molecules were further 
associated with infertility [3].
Catechol- and quinone-estrogens have been linked before to cancer (thyroid, breast and 
prostate) [12] and to auto-immunity [13]. In schistosomiasis it has to be seen, if and to what 
extent the catechols produced by S. haematobium induce carcinogenesis and infertility by 
changes in the hormonal environment (hormones are known to affect the immune response 
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also), and/or by the increase of the probability of mutations, The LC-MS-MS for the search 
of estrogen metabolites in infected patients is a non-invasive test, suitable especially for 
female genital schistosomiasis. With its potential to detect biomarkers of cancer and 
infertility associated to schistosomiasis, it could improve the public health in under-
resourced and under-served populations.
Potential Future Impact of catechol estrogens detection in schistosomiasis
Potentially, the possibility to detect catechols in the urine of infected patients offers new 
perspectives for controlling schistosomiasis-induced morbidity. An automated diagnostic 
method or point-of-care testing based on analysis of catechol estrogens in urine of S. 
haematobium infected persons could provide a novel, non-invasive tool to complement 
current approaches. The use of the recent high resolution mass spectrometry could be used 
without the need of standards and with higher throughput.
Major drawbacks of the use of LC-MS-MS as a diagnostic tool in 
schistosomiasis
The cost of new LC-MS instruments ranges from € 100,000 to € 600,000. In addition to 
initial purchase cost, machines require annual maintenance work. This type of contract 
currently cost approximately € 10,000 per year. It is estimated that analysis of one analyte 
per urine costs an average of €15. Therefore, the use of LC-MS for diagnostic and 
prognostic testing in schistosomiasis would be only cost-efficient when it is used for routine 
analysis [14].
The level of training and expertise varies among personnel working with LC-MS. 
Interpretation of data and the development of methods requires in-depth knowledge of both 
organic and inorganic chemistry. Maintenance of the instruments and troubleshooting 
requires the technical, mechanical and electronic skills of a scientist or engineer [14]. On the 
other hand. for the system operation and data analysis of the analytes in the urine of 
schistosome infected patients can be carried by a technician trained after analytical 
validation.
In future, LC-MS equipment would be a valuable tool for proper diagnosis of 
schistosomiasis. These are cheaper routine analyzers facilitating their application in endemic 
countries and may thus be applied at least in a context of an emerging economy country.
Concluding remarks
Further studies are necessary to identify and characterize production of these estradiol-like 
molecules in schistosomes and define their hormonal function(s) in the developmental cycle 
of this blood fluke.
Importance will be given to evaluate the specific effects of the estrogenic molecules 
identified in the lysates of schistosomes and to assess activities of specific catechol-
estrogens identified in the schistosome eggs. It will be informative to use either catechol-
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estrogens purified from eggs of S. haematobium and/or synthetic versions of these putative 
carcinogens.
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Figure 1. 
Major metabolic pathways in cancer initiation by estrogens [8].
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